CD14 and lung cancer: A larger cohort study evaluating immunotherapy response in lung cancer patients using differential IMC markers, identified CN23 neighborhood, consisting of five markers CD14, CD16, CD94, αSMA and CD117, most significantly associated with overall survival suggesting specific neighborhood interactions may have prognostic value80.